Brian Tyler, chairman of the management board of McKesson Europe, says: “Cormac has been an energetic and trusted leader of our UK and Ireland businesses. He has built a strong leadership team for Celesio UK and his warm and engaging personality made him many friends across community pharmacy and beyond. There is a genuine affection for him amongst our colleagues who value his ability to understand customers and patients and put them at the heart of everything we do.
“I am grateful for the dedication that Cormac has shown over the last few years and his leadership through an ever-changing external environment. I wish him every success for the future.”
During his tenure at the company (which includes LloydsPharmacy and AAH Pharmaceuticals), Cormac has overseen three major acquisitions, introduced the UK’s first Prescription Assembly Solution (PAS) that has revolutionised off-site dispensing and embedded a ‘customer first’ culture across the workforce which now numbers around 25,000.
Cormac has left with immediate effect and the remaining members of the Celesio UK Board will manage the business whilst a successor is sought, reporting to Brian Tyler.
Brian continues: “There is a strong and experienced management team in the UK consisting of Nigel Swift, Hilary Stables, Ruth Poole, Catherine McDermott and Marcus Hilger. Together with the entire business in the UK, this leadership team will be able to successfully navigate current and future challenges that the company faces.”
Notes to editors
Cormac Tobin was appointed Managing Director of Celesio UK in early 2013 after successfully leading the Celesio Group’s business in Ireland, DocMorris/Unicarepharmacy, for six years. He was appointed to the Leadership Team of LloydsPharmacy’s parent company, Celesio AG (now McKesson Europe) in September 2014. This role included regional responsibility for LloydsPharmacy Ireland.
Cormac was Retail Director of Superquinn for 29 years from 1977 to 2006. He started at Superquinn aged just 13, becoming Superquinn’s youngest store manager at age 23 and a board member by 2000.
Celesio UK is a leading provider of integrated healthcare services to the NHS specialising in medicines, pharmaceutical care and primary care patient services.
With almost 25,000 employees, nearly 1,900 community pharmacies, a UK-wide logistics network and dispensing in excess of 150 million items a year, Celesio UK works in partnership with the NHS, community pharmacies and medicines manufacturers to help UK citizens live longer, healthier and more positive lives. Celesio UK provides customers, the NHS and patients with high levels of service, value, efficiency and innovation.
Celesio UK is part of McKesson Europe and comprises LloydsPharmacy, AAH Pharmaceuticals, LloydsPharmacy Clinical Homecare, Masta, Online Doctor and Betterlife.
McKesson Europe is a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sector. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care.
With strong brands and about 39,000 employees, the group is active in 13 European countries (thereof with own operations in ten countries; additionally McKesson Europe manages operations in three countries and participates in one country in a joint venture). Every day, the company serves over 2 million customers – at more than 2,100 pharmacies of its own, at about 300 managed pharmacies and at over 5,700 participants in the brand partnership schemes. With 110 own and seven managed wholesale branches in Europe, McKesson Europe supplies more than 55,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products.
McKesson Corporation, San Francisco, USA, is the majority shareholder in McKesson Europe AG. McKesson is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology.